OncoSec is proud to partner with melanoma advocacy groups on its #TogetherAgainstCancer campaign

As part of OncoSec’s commitment to patients fighting melanoma, and all cancer-related diseases, we are proud to launch #TogetherAgainstCancer, a campaign focused on bringing together the cancer community to reinforce the courage, resilience and strength of those fighting this devastating disease.

We are partnering with the Melanoma Advocacy community to support many different initiatives that impact patients, care partners and their support community. Please follow us on Twitter, LinkedIn and email to stay connected on upcoming events and news.

Melanoma Clinical Trials: A Panel Discussion

OncoSec partnered with the Melanoma Research Foundation (MRF) to host a webinar, titled “Melanoma Clinical Trials: A Panel Discussion,” on Tuesday, May 19th.

The panel discussion featured Adil Daud, M.D., a medical oncologist at the University of California, San Francisco. Dr. Daud leads the UCSF melanoma research program and provided an overview of the current status of clinical trials, including OncoSec’s KEYNOTE-695 study, given the COVID-19 pandemic.

The discussion also featured Patrick Rebholtz, a person living with melanoma and clinical trial participant, and Brent Morris, a pediatrician and care partner to his wife. Patrick and Brent shared their own experiences with melanoma as well as what patients and care partners should know about clinical trial participation. The discussion was then opened for questions from participants.

You can listen to a replay of the webinar via the MRF’s website here.

Fran’s Story: The Importance of Early Detection

OncoSec’s product candidates are investigational and have not been approved by the FDA. The results described in the testimonials may not be representative of the patient experience as the product candidates remain investigational.